New daily pill for obesity shows promise in early trial

NCT ID NCT07652047

Recruiting now Disease control Sponsor: Corxel Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests a new daily pill called CX11 in 90 adults with obesity or overweight who also have weight-related health problems like high blood pressure or prediabetes. The study aims to see if the pill is safe and helps with weight loss compared to a placebo. Participants will take the pill for a set period, and researchers will track changes in body weight.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CX11 tablets
What this could lead to: If successful, this could lead to a new daily pill for weight loss in people with obesity or weight-related health issues.
What could go wrong: This is an early Phase 1b trial with only 90 participants, so safety and effectiveness are not yet proven. The drug may not work or could have side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY & OVERWEIGHT

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Corxel Investigational Site
RECRUITING

Austin, Texas, 78744, United States

Contact Email: •••••@•••••
Corxel Investigational site
RECRUITING

Las Vegas, Nevada, 89113, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.